Ever since the Institute organised its first scientific meeting over 80 years ago, input from the commercial sector has always played a vital role in success, and last year’s Biomedical Science Congress was no exception.
The Institute of Biomedical Science, in its various guises (IMLS, IMLT and, in the beginning, the Pathological and Bacteriological Assistants’ Association [PBLAA]) has been organising conference events since 1924. The Biomedical Science Congress is the most recent incarnation, having changed from the ‘Triennial’ format in 1995. Over the subsequent 14 years, there have been eight of these major biomedical science events, which have taken place biennially in September at the International Convention Centre in Birmingham.
Over those years, scientific and professional changes have cascaded through pathology with what seems like ever-increasing frequency – and the pace of change seems to show no sign of easing. At the same time, biomedical scientists are being asked to improve standards and the service they provide within the confines of increasingly limiting professional and budget constraints.
These changes are taking place against a scientific background, and science, by its very nature, does not stand still. New discoveries are embraced, older theories are challenged in the light of acquired knowledge and understanding, and working practices are changed.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.